M. Hagberg Thulin

Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts and bone microtumors

A. Wu, P. Albertsson, K. Jennbacken, 2020, EJNMMI Research.

Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment

Lisa U. Magnusson, Anders Olsson, P. Plas, 2016, The Prostate.

Analysis of regulator of G-protein signalling 2 (RGS2) expression and function during prostate cancer progression

Anna Linder, K. Welén, J. Damber, 2018, Scientific Reports.

Osteoblasts stimulate the osteogenic and metastatic progression of castration-resistant prostate cancer in a novel model for in vitro and in vivo studies

K. Jennbacken, K. Welén, J. Damber, 2013, Clinical & Experimental Metastasis.

Targeting sex steroid biosynthesis for breast and prostate cancer therapy

P. Härkönen, M. Hagberg Thulin, Matti Poutanen, 2023, Nature Reviews Cancer.